Related Experiment Videos
Intranuclear nemaline rod myopathy
Vassil Kaimaktchiev1, Hans Goebel, Nigel Laing
1Department of Pathology, Oregon Health & Sciences University, 3181 SW Sam Jackson Park Road, Portland, Oregon 97239, USA.
Muscle & Nerve
|February 16, 2006
Summary
Intranuclear nemaline rod myopathy, identified by alpha-actinin inclusions in myocyte nuclei, can progress with age. A specific ACTA1 gene mutation was found, but the patient shows stable development, suggesting a non-progressive course.
Area of Science:
- Neurology
- Genetics
- Pathology
Background:
- Nemaline rod myopathy is a neuromuscular disorder.
- Intranuclear inclusions are a rare finding in nemaline myopathy.
Observation:
- A case study of a boy with intranuclear nemaline rod myopathy.
- Muscle biopsies showed intranuclear inclusions immunoreactive for alpha-actinin, increasing with age.
- Genetic analysis identified a Val163Leu ACTA1 mutation.
Findings:
- The patient, despite initial developmental delay, achieved all milestones and remains clinically stable.
- Intranuclear rods may accumulate over time.
- The presence of intranuclear rods does not necessarily indicate a poor prognosis.
Implications:
- This case expands the understanding of intranuclear nemaline rod myopathy.
- It suggests that ACTA1 mutations can present with intranuclear inclusions.
- The findings challenge the assumption of a uniformly severe prognosis for intranuclear nemaline rod myopathy.